Buda, V.; Andor, M.; Ledeti, A.; Ledeti, I.; Vlase, G.; Vlase, T.; Cristescu, C.; Voicu, M.; Suciu, L.; Tomescu, M.C.
Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation. Int. J. Mol. Sci. 2017, 18, 164.
https://doi.org/10.3390/ijms18010164
AMA Style
Buda V, Andor M, Ledeti A, Ledeti I, Vlase G, Vlase T, Cristescu C, Voicu M, Suciu L, Tomescu MC.
Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation. International Journal of Molecular Sciences. 2017; 18(1):164.
https://doi.org/10.3390/ijms18010164
Chicago/Turabian Style
Buda, Valentina, Minodora Andor, Adriana Ledeti, Ionut Ledeti, Gabriela Vlase, Titus Vlase, Carmen Cristescu, Mirela Voicu, Liana Suciu, and Mirela Cleopatra Tomescu.
2017. "Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation" International Journal of Molecular Sciences 18, no. 1: 164.
https://doi.org/10.3390/ijms18010164
APA Style
Buda, V., Andor, M., Ledeti, A., Ledeti, I., Vlase, G., Vlase, T., Cristescu, C., Voicu, M., Suciu, L., & Tomescu, M. C.
(2017). Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation. International Journal of Molecular Sciences, 18(1), 164.
https://doi.org/10.3390/ijms18010164